FindTrial
Sign In

Clinical features and prognosis of NORSE

Clinical features and prognosis of NORSE

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091961
Enrollment
Unknown
Registered
2024-11-06
Start date
2024-08-12
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

NORSE group:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Consistent with epileptic status; 2. In the acute stage of the disease at admission; 3.Clinical and imaging data exist completely;

Exclusion criteria

Exclusion criteria: 1.A history of epilepsy; 2.Complicated with nervous system tumor; 3.A history of brain trauma, brain surgery, or cerebrovascular accident in the past year; 4. Epilepsy caused by acute poisoning, metabolic encephalopathy or acute brain structural lesions; 5.Intracranial infectious diseases with clear pathogens such as bacteria, tuberculosis and cryptococcus;

Design outcomes

Primary

MeasureTime frame
Clinical features and prognosis;Demographic characteristic;Blood test index;Cerebrospinal fluid examination indicators;Prognosis;—

Secondary

MeasureTime frame
Radiologic characteristic;—

Countries

China

Contacts

Public ContactLei Chen

West China Hospital of Sichuan University

leilei_25@126.com+86 189 8060 5819

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026